Development of bullous pemphigoid during treatment of psoriasis with adalimumab

Clinical and Experimental Dermatology

Volumn 34, Issue 7, 2009, Pages

  Stausbol Gron B ^a   Deleuran, M ^a   Sommer Hansen, E ^a   Kragballe, K ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CLOBETASOL; CORTICOSTEROID; ENALAPRIL; PREDNISOLONE;

ADULT; ANAMNESIS; BLOOD EXAMINATION; BULLOUS PEMPHIGOID; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; LETTER; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PRURITUS; PSORIASIS;

ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; DRUG ERUPTIONS; HUMANS; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; PSORIASIS;

EID: 70349497499     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.03204.x     Document Type: Letter

References (5)

1. Wilczek A, Sticherling M. Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship? Int J Dermatol 2006 45 : 1353 1357.
2. Lee JJ, Downham TF. Furosemide-induced bullous pemphigoid. case report and review of literature. J Drugs Dermatol 2006 5 : 562 564.
3. Smith EP, Taylor TB, Meyer LJ, Sone JJ. Antigen identification in drug-induced bullous pemphigoid. J Am Acad Dermatol 1993 29 : 879 882.
4. Ramos-Casals M, Brito-Zerón P, Munoz S et al. Autoimmune diseases induced by TNF-targeted therapies. Analysis of 233 cases. Medicine 2007 86 : 242 251.
5. De Bandt M, Sibilia J, Le Loët X et al. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 2005 7 : R545 51.